Fair Market Value

The Cost of Inadequate Data & Opportunity for Advancement

An exclusive panel session that dives into the impact of Fair Market Value (FMV) on clinical research and the importance of having access to global, industry-indicative data to kick start your trials.

Topics include:

Why FMV is critical to the pharma industry now more than ever
Impact of COVID-19 on FMV
How FMV data has been historically problematic
Opportunities for enhanced startup processes through better data & workflow connectivity

First Name

Last Name

Company Name

Company Type

How did you hear about us?

Comments

Greenphire, Inc. will use the information you provide above to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, please review our Privacy Policy.